8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)
Published . Updated .
8-K - SUPERNUS PHARMACEUTICALS filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- SUPN Supernus Pharmaceuticals+1.0% 14d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SUPN | -2.79% | -1.91% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| XBINo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0001104659-26-121103 Size: 187 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Source: sec-edgar
The price since 2 Nov 2026: Supernus Pharmaceuticals (SUPN) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Supernus Pharmaceuticals (SUPN) | three days earlier | -1.91% | final price |
| Supernus Pharmaceuticals (SUPN) | five days earlier | -2.79% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)”
Companies carried with this story
- SUPN Supernus Pharmaceuticals
Supernus Pharmaceuticals (SUPN) is linked, with no stored direction, high confidence in the 2 Nov 2026 story “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> SUPN
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer).” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer).” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
In “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
For “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
For “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
For “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” reaches Supernus Pharmaceuticals (SUPN)
The 2 Nov 2026 story “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” names Supernus Pharmaceuticals (SUPN) because of this story.
Supernus Pharmaceuticals (SUPN) is on the page because SEC 8-K filing -> direct issuer disclosure -> SUPN
Select Sector Spdr Tr (XLV) is here too. Its reason reads: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Price levels for Supernus Pharmaceuticals (SUPN)
SUPN traded between 37.54 and 44.05 across 12 sessions. The latest close on file is 41.95.
How strong the case is around Supernus Pharmaceuticals (SUPN)
46 out of 100
“8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.